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The activity of histaminergic neurons in the tuberomammillary nucleus (TMN) of the hypothalamus correlates with an animal’s behav-
ioral state andmaintains arousal.We examined howGABAergic inputs onto histaminergic neurons regulate this behavior. A prominent
hypothesis, the “flip-flop” model, predicts that increased and sustained GABAergic drive onto these cells promotes sleep. Similarly,
because of the histaminergic neurons’ key hub-like place in the arousal circuitry, it has also been suggested that anesthetics such as
propofol induce loss of consciousness by acting primarily at histaminergic neurons. We tested both these hypotheses in mice by genet-
ically removing ionotropic GABAA or metabotropic GABAB receptors from histidine decarboxylase-expressing neurons. At the cellular
level, histaminergic neurons deficient in synaptic GABAA receptors were significantly more excitable and were insensitive to the anes-
thetic propofol. At the behavioral level, EEGprofiles were recorded in nontetheredmice over 24 h. Surprisingly, GABAergic transmission
onto histaminergic neurons had no effect in regulating the natural sleep–wake cycle and, in the case of GABAA receptors, for propofol-
induced loss of righting reflex. The latter finding makes it unlikely that the histaminergic TMN has a central role in anesthesia. GABAB
receptors on histaminergic neurons were dispensable for all behaviors examined. Synaptic inhibition of histaminergic cells by GABAA
receptors, however, was essential for habituation to a novel environment.
Introduction
The posterior hypothalamus contains circuitry governing the
transition betweenwake and sleep (Haas and Panula, 2003; Saper
et al., 2010). Within this area, the widely projecting and arousal-
promoting histaminergic neurons, whose cell bodies are found
exclusively in the tuberomammillary nucleus (TMN) (Watanabe
et al., 1983; Panula et al., 1984), have a striking “wake-on, sleep-
off” profile: histaminergic neurons do not fire action potentials
during non-rapid eye movement (NREM) or REM sleep, but fire
tonically during wake (Haas and Panula, 2003; Takahashi et al.,
2006, 2010; Sakai et al., 2010). Consequently, histaminergic neu-
rons have beenplaced at the center of the “flip-flop” hypothesis of
sleep regulation (Saper et al., 2010). In this model, continuous
GABAergic and galaninergic inhibition from sleep-active neu-
rons in preoptic hypothalamic nuclei onto histaminergic cells has
been suggested to convey a sleep drive, which, through switching
off histaminergic neurons as well as other arousal centers, allows
sleep induction and maintenance (Sherin et al., 1996, 1998; Szy-
musiak et al., 1998; Saper et al., 2010).
Given the histaminergic system’s wide influence on brain
function and its putative role in sleep–wake control, it was com-
pelling to suggest that some anesthetics might act selectively on
GABAA receptors on these neurons to induce loss of conscious-
ness (LOC) (Nelson et al., 2002; Zecharia et al., 2009). Allosteric
modulators such as the anesthetic propofol increase GABA’s ap-
parent affinity at GABAA receptors, enhancing the chloride cur-
rent (Rudolph andMohler, 2004; Bonin andOrser, 2008; Franks,
2008; Olsen and Sieghart, 2009; Vithlani et al., 2011). Because
histaminergic neurons express theGABAA receptor1,2,5,1,
3, and 2 subunit genes (Sergeeva et al., 2002, 2010; Zecharia et
al., 2009; Yanovsky et al., 2012) we and Nelson et al. (2002) hy-
pothesized these cells could be primary targets for propofol.
When the GABAA receptor antagonist gabazine (SR95531) was
microinjected directly into the TMN, it reduced the duration of
loss of righting reflex (LORR) obtained from systemically admin-
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istered propofol (Nelson et al., 2002). Furthermore, the GABAA
receptor agonist muscimol produced a dose-dependent LORR
when injected into the TMN (Nelson et al., 2002), and this evi-
dence has been used to further support the flip-flop hypothesis of
the wake-to-sleep transition (Saper et al., 2010).
These injection approaches are open to interpretation. In the
mouse, the small size of the ventral (Fig. 1) and other TMN
regions makes precision lesions and drug infusions (e.g., mus-
cimol) to study histaminergic neurons challenging. Thus, in
principle, targeting all histidine decarboxylase (HDC) neurons ge-
netically would be best. For this project, we re-examined, using cell
type-selective genetic targeting withHDC-Cremice, how GABAer-
gic inhibition of histaminergic neurons influences the sleep–wake
cycle and the response to a clinically important GABAergic anes-
thetic, propofol.
Materials andMethods
All procedures involving experimental mice were in accordance with the
United Kingdom Animals (Scientific Procedures) Act 1986.
Generation of HDC-Cre mice
Exon 12 of the hdc gene was targeted by homologous recombination
in mouse embryonic stem cells (type RI), placing the Cre ORF with an
enhanced internal ribosomal entry site (IRES2i) between the stop
codon and the polyadenylation signal of the hdc gene (Fig. 2A). The
genomic DNA containing the mouse hdc gene (ENSEMBL gene ENS-
MUSG00000027360, located on chromosome 2) (Joseph et al., 1990;
Suzuki-Ishigaki et al., 2000) was obtained on a bacterial artificial
chromosome (BAC) by screening the PubMed Clone finder library
(BAC no. RP23-361E18).
An internal 10kb SpeI-BglII fragment including exons 10–12 of the
hdc gene was identified to serve as homologous arm for the targeting and
was ligated into a modified pBluescript (Agilent Technologies) vector
with a SpeI-BglII (underlined) adapter (sense: 5-TCGAGACTAGTCCC
AGATCTC-3; and antisense: 5-TCGAGAGATCTGGGACTAGTC-3)
in the polylinker region. Into this vector a CMV promoter-EGFP cDNA-
SV40-polyA cassette was introduced outside the homologous region to
serve as a detector for nonhomologous recombination (negative selec-
tion). Fluorescent stem cell colonies were not expected to be homologous
recombinants. The EGFP was excised as a BamHI/XbaI fragment from
pEGFP-N1 (Clontech) and placed into an expression vector to incorpo-
rate the CMV enhancer/promoter and the SV40 polyA into the design.
Then the whole CMV-EGFP-pA cassette was excised as a SalI/NotI frag-
ment and placed into the vector carrying the genomic fragment of the
HDC gene. An internal 4 kb XhoI-AgeI fragment, containing exon 12,
was cloned into pLitmus28 (New England Biolabs) to perform site-
directed mutagenesis on it, introducing a unique SalI site 28 bp 3 of the
hdc gene’s stop codon using the primer pair, sense: 5-CCTCAATCAG
AATGCAAGAGTCGACGTGCCTGTGCTTCAGGGAG-3; and anti-
sense: 5-CTCCCT GAAGCACAGCAGGCACGTCGACTCTTGCATT
CTGATTGG-3, and then were recloned into the donor plasmid. The
introduced SalI site is underlined. An improved IRES2i was placed up-
stream of a humanized Cre recombinase reading frame (Shimshek et al.,
2002) in the pLitmus38 vector. An frt-neo-frt cassette (Cope et al., 2004)
was ligated as a SpeI fragment into the NheI site of the pL38 Ires2iCre
plasmid. A linker was inserted (sense: GGTACCGAATTCGGGTCGAC
GGC; and antisense: TTAAGCCGTCGACCCGAATTCGGTACCGC),
introducing a unique EcoRI site (in italics) into the construct upstream
of the IRESCre that would be later used in the genomic screening of
targeted ES cells. The IRES-Cre-frt-neo-frt cassette was excised using SalI
and cloned into the unique SalI site of the pBluescript-HDC (exons10–
12)-SpeI-BglII-CMVeGFP-pA plasmid to complete the targeting vector.
The construct was confirmed by sequencing across all joins (Fig. 2A).
The targeting construct was linearized with NotI outside the short
homology arm at the 3 end of the targeting vector, and 40 g were
electroporated with 240 V and 500 F into 2 10 7 RI ES cells (Nagy
et al., 1993). After 10 d under G418 (Geneticin, 200 mg/ml) selection,
non-GFP-fluorescent ES cell clones were picked and expanded for
analysis. Approximately 600 cell colonies were screened. The probe
(Fig. 2A, Probe A) to perform Southern blotting was generated by
PCR from the EcoRI genomic clone of the HDC gene. The primer pair
for the 5 external probe was as follows: 5A_S: 5-CCATTCATCCGC
Figure 1. Coronal sections showing the relative sizes of selected mouse brain regions The
caudate–putamen (Cpu), locus ceruleus (LC), reticular thalamic nucleus (Rt), andVTMare high-
lighted in red (adapted from Franklin and Paxinos, 2008).
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GGTCATCTGGGAAACCATTG-3; and 5A_
AS: 5-GCTATAGA ACTAAGTGAAAGGA
AACTTGGTTG-3.
Genomic DNA from the ES cells was di-
gested with EcoRI, blotted, and hybridized
with 32P-labeled 5 external probe (Fig. 2A,
Probe A). One clone was found targeted cor-
rectly. The targeted ES cell clone was injected
by genOway into C57BL/6J blastocysts (Jack-
son Laboratories) to generate chimeric mice.
Chimeras were selected for breeding with
C57BL/6J mice to generate a stable mouse line,
HDC-Cre. To remove the neo cassette from the
genome, HDC-Cre mice were bred with Flp
deleter mice (Rodríguez et al., 2000). Absence
of the neo cassette was verified by Southern
blot analysis with a neo probe.
Generation of HDC-EGFP mice
A second targeting vector was constructed so
that, in addition to Cre recombinase, an EGFP
reading frame was also driven from the HDC
gene: i.e., a tricistronic hdc gene was created
(HDC-IRES-EGFP-IRES-Cre). The construc-
tion was similar to the one described for the
HDC-Cre line. To transfer the IRES2i-EGFP as
a BamHI fragment into pBluescript, a linker
was inserted into the NotI site after the EGFP
reading frame to introduce a second BamHI
site (in italics) at the 3 end (primer pair: 5-
GGCCAAGGATCCAA-3; and 5-GGCCTT
GGATCCTT-3). An IRES2i-EGFP-IRES2i-
Cre cassette was excised as the SalI-NheI frag-
ment and transferred into pLitmus38 via SalI/
NheI sites. Into this plasmid, a SpeI-frt-neo-
frt-SalI-SpeI fragment was inserted into the
NheI site at the 3 end. To apply the same
screening strategy as for the HDC-Cre mice, a
linker containing an EcoRI site (in italics) was
inserted, using the following primer pair: 5-
GGTACCGAATTCGGGTCGACGGC-3 and
5-TTAAGCCGTCGACCCGAATTCGGTAC
CGC-3. The IRES2i-EGFP-IRES2i-Cre-frt-
neo-frt cassettewas excisedusing SalI and cloned
into the unique SalI site of the pBluescript-HDC
(exons10–12)-SpeI-BglII -CMVeGFP-pA plas-
mid, described in the HDC-Cre section above,
to complete the targeting vector. The construct was confirmed by se-
quencing across all recombinant joins. The NotI site of the pBluescript
polylinker served to linearize the targeting construct before electropora-
tion in ES cells (Fig. 2B). The initial assay for correct targeting was the
same as for the HDC-Cre line (see above). One clone, from a screen of
500 stem cell colonies, was expanded and injected into blastocysts at
MRC Harwell. Germline transmission was confirmed by Southern
blotting (Fig. 2B) and PCR of ear genomic DNA with EGFP-specific
primers. The neomycin cassette was removed by crossing with Flp deleter
mice (Rodríguez et al., 2000).
Mouse breeding
For the experimental breedings, all the offspring were genotyped by PCR
analysis using genomic DNA from ears or tails and the following specific
primers: Cre: forward: 5-GTGTGGCTGCCCCTTCTGCC-3; reverse: 5-
AGCCTCACCATGGCCCCAGT-3 (250 bp) (Shimshek et al., 2002);
HDC-2 LoxP: forward: 5-GTCATGCTAAATATCCTACAGTGG-3;
reverse: 5-GGATAGTGCATCAGCAGACAATAG-3 (213 bp wild-type;
250 bp floxed allele) (Wulff et al., 2007); HDC-B1 LoxP: forward: 5-TG
GGGTGTGTCCTACATGCAGCGGACGG-3;reverse:5-GCTCTTCACC
TTTCAACCCAGCCTCAGGCAGGC-3 (526 bp wild-type 742 bp floxed
allele) (Haller et al., 2004); and EGFP: forward: 5-CATTGTATGGGATC
TGATCTG-3; reverse: 5-TGAACTTGTGGCCGTTTA-3 (224bp).Toas-
sess Cre recombinase expression, theHDC-Cremice were crossed with the
ROSA26-lacZmice (Soriano, 1999). To generate the HDC-2 and HDC-
B1 animals, HDC-Cre mice were crossed with the 2loxI77 (Wulff et al.,
2007) or loxGABAB1mice (Haller et al., 2004). Experiments used adultmice
of either sex homozygous for the conditional 2 or GABAB1 allele, and
heterozygous for the HDC-Cre transgene (HDC-2) and HDC-Cre-
negative littermate controls.
2loxI77 mice. The 2 subunit is essential for the GABAA receptor’s
placement at the postsynaptic membrane and for a full single-channel
conductance (Pritchett et al., 1989; Seeburg et al., 1990; Gu¨nther et al.,
1995; Lorez et al., 2000; Schweizer et al., 2003;Wulff et al., 2007, 2009a,b;
Tretter et al., 2009). Genetically removing the 2 subunit eliminates fast
synaptic inhibition (Schweizer et al., 2003, 2007, 2009a,b), andmice with
a total knockout of the 2 subunit gene die postnatally (Gu¨nther et al.,
1995). The 2loxI77 line has been previously used by us to selectively
remove synaptic GABAA receptor-mediated inhibition from Purkinje
cells (Wulff et al., 2007,b) and other parvalbuminergic cells (Wulff et al.,
2009a; Leppa¨ et al., 2011). The F77I mutation does not affect the physi-
ological properties of the GABAA receptor complex (Cope et al., 2004;
Wulff et al., 2007), mice with the F77I mutation appear unimpaired on
tests such as SHIRPA (Cope et al., 2004; Wulff et al., 2007; see below,
SHIPRA analysis), and there is no effect on IPSC properties in a range of
cell types (e.g., hippocampal pyramidal cells, hippocampal interneurons,
Figure 2. Gene-targeting strategy to produce the HDC-Cre and HDC-EGFP knock-in mouse lines. A, The IRES-Cre cassette was
placed into exon 12 of the hdc gene, between the stop (TAG) codon and the polyadenylation (pA) signal. An frt-flanked neomycin
resistance genewas inserted downstream for positive selection in ES cells. For negative selection, we used a GFP-expressing gene,
which flanked the3homologyarm, andanalyzednonfluorescent colonies. After successful targeting, theneomycin cassette (neo)
was removedbyFlp recombinase togive the final targetedallele.B, The IRES-EGFP-IRES-Cre cassettewasplaced intoexon12of the
hdc gene, between the stop codon and the polyadenylation signal. The strategywas identical to that for theHDC-Cre line described
above. Theautoradiographs showaSouthernblot analysis of theF1generations.GenomicDNAwasdigestedwithEcoRI. Blotswere
hybridized with 32P-labeled probe A. R, EcoRI; S, SpeI; B, BglII.
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cerebellar Purkinje cells, and cerebellar stellate and basket cells) (Cope et
al., 2005; Wulff et al., 2007).
Lox GABAB1 mice. The GABAB R1 subunit is an essential component
of all GABAB receptors (Gassmann and Bettler, 2012); mice with a dis-
rupted GABAB1 subunit gene have no GABAB receptor responses, have
spontaneous epileptic seizures, and can die postnatally depending on the
genetic background (Prosser et al., 2001; Schuler et al., 2001). Mice with
the floxed GABAB1 allele used here have lox511 sites placed around
exons 7 and 8 of the GABAB1 gene (Haller et al., 2004).
In situ hybridization
In situ hybridization was performed as previously described (Wisden and
Morris, 1994). The oligodeoxyribonucleotide sequences used were as fol-
lows:HDC:5-GCTGTCGGGTTCCTCGGGAGCACTCGCAGGTAGCTG
GGCTCGCAG-3; 2-Ex4: 5-GTGTCTGGAATCCAGATTTTCCCCAC
CATATTGCTATTCAAC-3; and GABAB-R1: 5-GAGGAGTTCATG
GCCCGGTAGATTTGGTCTGTAATGGTCTGGTTG-3.
Nonperfused brains were removed and frozen on dry ice. Sections (14
m) were cut on a cryostat, mounted onto poly-L-lysine-coated slides,
and dried at room temperature. Sections were fixed in 4% paraformal-
dehyde, washed in PBS, and dehydrated into 95% ethanol for storage at
4°C. Before hybridization, sections were removed from ethanol and al-
lowed to air dry. Probes (0.3 pmol/l) were 3 end labeled using terminal
deoxynucleotidyl transferase (Roche Diagnostics) and a 30:1 molar ratio
of  33PdATP (250 Ci/l; PerkinElmer) to oligonucleotide. Labeled
probe, dissolved in hybridization buffer, was applied to sections. Hybrid-
ization buffer contained 50% formamide/4 SSC/10% dextran sulfate
(1 SSC: 0.15 M NaCl, 0.015 M Na-citrate). Hybridization was at 42°C
overnight. Sections were washed with 1 SSC at room temperature for 5
min, 1 SSC at 65°C for 40 min, 0.1 SSC for 1 min at room tempera-
ture, and 70%ethanol for 1min at room temperature before 95%ethanol
dehydration. Images were generated from 1 to 2 week exposures to Biomax
MR x-ray film (Eastman Kodak). To assess nonspecific labeling of the sec-
tions, each labeled oligodeoxyribonucleotide was hybridized to brain sec-
tions with a 100-fold excess of unlabeled oligodeoxyribonucleotide.
Immunohistochemistry and -galactosidase labeling
Adult mice were transcardially perfused with ice-cold 4% paraformalde-
hyde (PFA; obtained as a 16% solution from Thermo Scientific) in PBS
(Sigma-Aldrich) at pH 7.4. Brains were removed and post-fixed over-
night before cryoprotection with 30% sucrose in PBS. Brains were frozen
on dry ice, and 40 m coronal sections were cut using a vibratome.
Free-floating sections were washed in PBS three times for 10 min, per-
meabilized in PBS plus 0.4% Triton X-100 for 30 min, blocked by incu-
bation in PBS plus 4–10%normal goat serum (NGS), 0.2%TritonX-100
for 1 h (all at room temperature), and subsequently incubated with a
primary antibody diluted in PBS plus 2% NGS overnight at 4°C. Incu-
bated slices were washed three times in PBS plus 1% NGS for 10 min at
room temperature, incubated for 2 h at room temperature with second-
ary antibody in PBS plus 1% NGS, and subsequently washed three times
in PBS plus 1% NGS or PBS alone for 10 min at room temperature.
Primary antibodies used were rabbit polyclonal EGFP (Invitrogen,
1:1000), guinea pig polyclonal HDC (American Research Products, 1:200),
rabbit polyclonal HDC (ImmunoDiagnostics, 1:1000), mouse monoclonal
-Gal (Promega, 1:5000), rabbit polyclonal2 (kindly donated by Professor
Werner Sieghart, University of Vienna, Vienna, Austria, 1:200), and rabbit
polyclonal anti-GABAB1 antibody Ab25, diluted 1:1000 (Engle et al., 2006).
Secondary antibodies were Alexa Fluor 488 goat anti-rabbit IgG (1:1000),
Alexa Fluor 594 goat anti-guinea pig IgG (1:1000), Alexa Fluor 488 goat
anti-mouse IgG (Invitrogen, 1:1000), CY3 goat anti-rabbit IgG (Stratech
Scientific, 1:1000). For immunostaining after experimental recordings,
neurons were filled by adding biocytin to the pipette solution. Slices
were fixed with a freshly prepared solution of 4% 1-Ethyl-3(3-
dimethylamino-propyl)carbodiimide and 1% N-hydroxysuccinimide in
0.1 M phosphate buffer (PB), pH 7.4 (2–12 h at 4°C) and then stainedwith a
rabbit anti-histamine (Millipore Bioscience Research Reagents, 1:1000)
polyclonal antibody (Panula et al., 1984). Sliceswere then incubated at room
temperature with sheep anti-rabbit Cy3 (1:500) and streptavidin-Alexa 488
(Invitrogen, 1:200). Slices were analyzed using an upright fluorescentNikon
eclipase 80i or a Zeiss LSM 510 confocal microscope.
-galactosidase (lacZ) staining was performed as previously described
(Bahn et al., 1997). Brain sections were prepared as described above and
incubated free floating in 5-bromo-4-chloro-3-indolyl--galactoside
(X-Gal) at 37°C (Bonnerot and Nicolas, 1993). After X-Gal staining,
sections were post-fixed in ice-cold 4%PFA for 15min, rinsed in 100mM
PB, pH 7.4, and mounted.
Brain slice electrophysiology
We recordedwhole-cell action potential firing and examinedGABAergic
currents in histaminergic neurons of the posterior hypothalamus [Fig. 1,
ventral tuberomammillary (VTM) nucleus] and dorsal lateral geniculate
(DLG) nucleus in acute coronal slices (Bright et al., 2007; Zecharia et al.,
2009).
Adult mice were deeply anesthetized with halothane and killed by
decapitation. The brain was rapidly removed and immersed in ice-cold
slicing solution [slicing ACSF contained the following (in mM): 2.5 KCl,
1 CaCl2, 5 MgCl, 1.25 NaH2PO4, 26 NaHCO3 and 11 glucose] bubbled
with 95%O2/5%CO2. The tissue block was cut between the cerebellum
and optic tract, and brain slices were produced with a vibratome tissue
slicer (Campden Instruments). Coronal slices were cut at a thickness of
250 m and transferred to a holding chamber containing cold slicing
ACSF continuously bubbled with 95%O2/5%CO2. Once slicing was
complete, the holding chamber was transferred to a 37°C heat block for
15min, after which the slicing ACSFwas gradually exchanged for record-
ing ACSF [which contained the following (in mM): 125 NaCl, 2.5 KCl, 2
CaCl2, 2MgCl, 1.25NaH2PO4, 26NaHCO3, and 11 glucose, pH7.4when
bubbled with 95%O2/5%CO2] over 40 min, then allowed to reach room
temperature before electrophysiological recording experiments.
Neurons were visualized by using a fixed-stage upright microscope
(Slice Scope Pro 1000, Scientifica) fitted with a high numerical aperture
water-immersion objective (Olympus, 40/0.8WLUMPlanFLN), and a
digital camera. The recording chamber was continuously perfused with
external solution (containing 1.5 M propofol from a 15 mM ethanolic
stock when appropriate) via a gravity perfusion system at a rate of 3
ml/min. Patch pipettes were fabricated from thick-walled borosilicate
glass capillaries (1.5 mm outer diameter, 0.86 mm inner diameter; Har-
vard Apparatus) using a two-step vertical puller (Narishige PC-10). Pi-
pette resistances were typically 5 M when back-filled with internal
solution.
We identified histaminergic neurons by the presence of hyper-
polarization-activated current (Ih) and a transient outward current
(Stevens et al., 2001), their spontaneous firing activity, and/or double-
immunostaining for histamine and biocytin (included in the pipette so-
lution at 1.5 mg/ml, Sigma). We visually identified the DLG nucleus
under low power and selected large (50 pF) relay neurons within this
area. For examination of IPSCs, we performed whole-cell patch record-
ings in voltage-clamp (60 mV) using internal pipette solutions con-
taining the following (in mM): 140 CsCl, 4 NaCl, 0.5 CaCl2, 10 HEPES, 5
EGTA, and 2 Mg-ATP; the pH was adjusted to 7.3 with CsOH. For
examination of neuronal firing properties, we recorded in current-clamp
using internal solutions containing the following (in mM): 145
K-gluconate, 4 NaCl, 5 KCl, 0.5 CaCl2, 5 EGTA, 10 HEPES, 4 Mg-ATP,
and 5 sucrose; the pH was adjusted to 7.3 with KOH.
The amplifier headstage was connected to an Axopatch 200B or 700B
amplifier (Molecular Devices). Fine and course movements of the pi-
pettes were controlled by micromanipulators (PatchStar, Scientifica)
mounted on a fixed platform.The amplifier current outputwas filtered at
10 kHz (3 dB, eight-pole low-pass Bessel filter) and digitized at 50 kHz
using a Cambridge Electronic Devices (CED 1401 mk II) or National
Instruments digitization board (NI-DAQmx, PCI-6052E). Data acquisi-
tion was performed by using WINWCP (version 4.1.2) and WINEDR
(version 3.0.9), kindly provided by JohnDempster (University of Strath-
clyde, Glasgow, UK).
SHIPRA analysis
A basic behavioral characterization of the mice was performed. Naive
adult animals were screened in a modified SHIRPA (http://empress.har.
mrc.ac.uk/browser/?sop_id 	 10_002_0) by an observer blind to the
genotype (Leppa¨ et al., 2011). Twenty-three primary physiological and
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behavioral parameters were recorded and videotaped in a glass viewing
chamber (height, 18 cm; diameter, 14 cm) and open field arena (27 27
cm). Table 1 shows the SHIRPA data for the HDC-2 and HDC-B1
mice.Wilcoxon signed rank tests orMann–Whitney tests, used as appro-
priate, revealed no significant differences between the respective knock-
outs and littermate controls.
EEG recording and behavior
Mice were implanted with EEG and EMG electrodes under general anes-
thesia (Pang et al., 2009). After a minimum 7 d recovery period, we
recorded cortical activity and muscle tone using Neurologger 2 devices,
as described previously (Pang et al., 2009; Vyssotski et al., 2009). These
data loggers connect directly to electrode pins, which enabled us tomake
untethered recordings (i.e., freely moving mice) in the home cage or
other environment. For all recordings, mice were acclimatized to the
Neurologger 2 by attaching a mock logger (similar size and weight) for
2–3 d before the experiment. For natural sleep recordings, which all took
place in the animals’ home cages, animals were connected to the Neu-
rologger 22 h before “lights on” andmoved to a sound-proof chamber.
There were always at least 2 mice in the chamber per recording. Mice
were left undisturbed for at least 24 h to enable a full sleep–wake cycle (12
h light, 12 h dark) to be recorded. For litter change experiments, mice
were connected to the Neurologger 2 and transferred to the sound-proof
chamber in their home cage 3 h before lights on, and transferred to a new
home cage containing fresh bedding 1 h before lights on. Mice were left
undisturbed overnight to assess their response to the new environment.
The sleep state (REM;NREM; orWAKE) was scored automatically using
an established protocol (Costa-Miserachs et al., 2003; Pang et al., 2009).
For propofol-induced LORR, mice were placed in a restraining tube
and injected (intravenously in the tail) with 10 or 30 mg/kg propofol
(Rapinovet; Schering-Plough Animal Health). Mice were removed from
the tube and placed on a heatedmat. Animals were turned onto their side
every 30 s, and the time to spontaneous righting was recorded. For
propofol-induced motor sedation, mice were injected (50 mg/kg, i.p.)
and immediately placed in an Activity Monitor (Med Associates). The
coordinates of the animal were recorded using two orthogonal sets of 16
infrared beams for 10 min. Data were analyzed with Activity Monitor
software (MedAssociates). TheActivityMonitorwas thoroughly cleaned
with ethanol between experiments. To reduce our cohort size, we com-
pared propofol motor sedation with vehicle (20% Intralipid, Fresenius
Kabi) in a single animal by paired experiments. Experiments were at least
7 d apart, and the injection order (vehicle versus propofol) was random-
ized across the cohort.
Data are presented as the mean 
 SEM, and an unpaired Student’s t
test was used for statistical analysis (unless otherwise stated), using
Welch’s correction for unequal variance, when appropriate. All statistical
analysis was performed using GraphPad Prism version 4.03 for
Windows.
Results
Genetic targeting of histaminergic neurons
We first generated amouse line that would allow us to specifically
manipulate histaminergic (HDC-expressing) neurons. For the
hdc gene, we chose to knock in Cre to the endogenous hdc allele
on chromosome 2 at the end of the hdc reading frame rather than
use a BAC transgene; the small (12 Kb) hdc gene is located in a
gene-dense area, and, depending on the size of any BAC used for
a transgene, extra genes might be introduced on the BAC. By
homologous recombination in embryonic stem cells, an IRES-
Cre recombinase cassette was placed after the stop codon in exon
12 of the mouse hdc gene on chromosome 2 to create the hdc-Cre
knock-in allele (Fig. 2A). ThemRNAproduced from this hdc-Cre
allele encodes bothHDC protein and Cre recombinase (Fig. 2A).
In situhybridizationwith anHDC-specific oligonucleotide probe
confirmed that in adult wild-type mice HDC mRNA was re-
stricted to the TMN (Fig. 3A) (Bayliss et al., 1990; Karlstedt et al.,
2001). We mapped hdc-Cre gene expression by crossing HDC-
Cre mice with ROSA26-lacZ reporter mice (Fig. 3C,E,F) (So-
riano, 1999). Adult brains of these offspring had the expected
-galactosidase expression in the TMN and ependyma (Fig. 3C);
-galactosidase staining, which appeared as puncta within the
cells, was colocalized with HDC immunoreactivity (Fig. 3D).
-galactosidase staining was absent from most other adult
brain regions of HDC-Cre  ROSA26-lacZ brains (e.g., olfac-
tory bulb, neocortex, hippocampus, striatum, most of the
thalamus and hypothalamus, the raphe nuclei, and locus ce-
ruleus). However, lacZ was expressed, unexpectedly, in a few
thalamic nuclei: the dorsal lateral geniculate nucleus (Fig.
3E,F ); the ventral posterolateral thalamus (VPL) nuclei (Fig.
3F ); and scattered cells in the post-thalamic nucleus. There
was also lacZ expression in the ventral medial hypothalamus
(VMH) (Fig. 3F ), some cells in the inferior colliculi, and some
cerebellar Purkinje cells. ROSA26-lacZ gene expression in
these areas probably originated from transient hdc-Cre gene
expression during development (see Discussion).
We also produced a tricistronic knock-in mouse line with an
extra IRES element at the hdc locus, so that the mRNA would
contain three reading frames (HDC-IRES-EGFP-IRES-Cre) (Fig.
2B), and EGFP would be uniquely expressed in histaminergic
neurons; in this additional line, however, Cre was not translated
sufficiently from the second IRES element to enable recombina-
tion. So we termed this tricistronic line simply “HDC-EGFP.”
Unlike the case for theHDC-Cre ROSA26-lacZ crosses, which
reflect the developmental history of the hdc gene expression,
EGFP will only be present in cells when the hdc-EGFP gene is
currently expressed. Thus, the HDC-EGFP line was convenient
for mapping HDC cells in adult mice by immunohistochemistry
with an EGFP-specific antibody (Fig. 4). HDC-EGFP neurons
were scattered throughout the TMN, dispersed as bilateral clus-
ters in the VTM, medial tuberomammillary (MTM), and dif-
fuse tuberomammillary (DTM) area; there were also positive
cells in the dorsal part of the ependymal wall of the third
Table 1. Results of the SHIRPA screen on HDC-2 and HDC-B1mice compared
with littermate controls
Parameter measured
HDC-2
(n	 13)
Littermate
(n	 11)
HDC-B1
(n	 10)
Littermate
(n	 10)
Body position 0 0 0 0
Appearance 0 0 0 0
Whiskers 0 0 0 0
Tremor 0 0 0 0
Palpebral closure 0 0 0 0
Lacrimation 0 0 0 0
Defecation 0 0 0 0
Grooming 0 0 0 0
Transfer arousal 0 0 0 0
Locomotor activity 0 0 0 0
Gait 0 0 0 0
Stretch 0 0 0 0
Tail elevation 0 0 0 0
Startle response nm nm 0 0
Touch escape 0 0 0 0
Positional passivity 0 0 0 0
Trunk curl 0 0 0 0
Limb grasping 0 0 0 0
Pinna reflex 0 0 0 0
Corneal reflex 0 0 0 0
Contact righting reflex 0 0 0 0
Evidence of biting 0 0 0 0
Vocalization 0 0 0 0
Weight (g) 34.31
 1.5) 37.73
 0.9 29.9
 1.2 31.7
 2.0
nm, Not measured. There was also no difference in the weight of knockouts compared to littermates.
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ventricle (Fig. 4A), in agreement with Karlstedt et al. (2001).
By double staining, nearly all EGFP cells were HDC positive
(Fig. 4B–E). In contrast to results with the brains from
ROSA  HDC-Cre mice (Fig. 3C,E,F ), but agreeing with in
situ hybridization using HDC probes on wild-type mouse
brain sections (Fig. 3A), no other brain areas in HDC-EGFP
mice had EGFP immunoreactivity. So, in the adult mouse
brain, hdc gene expression is restricted to the TMN (see
Discussion).
Specific removal of synaptic GABAA receptors from
histaminergic neurons
Histaminergic neurons from the TMN express a mixture of
GABAA receptor subunit genes (1, 2, 5, 1, 3, and 2) (Ser-
geeva et al., 2002; Zecharia et al., 2009; Yanovsky et al., 2012),
whichmeans the receptors are2 types.We examined how fast
GABAergic inhibition onto histaminergic neurons regulates the
sleep–wake cycle by crossingHDC-Cremice with a line contain-
ing a conditional gabrg2 allele (2I77lox) (Wulff et al., 2007),
where exon 4 is flanked by loxP sites, to produceHDC-2 mice.
Removal of the 2 subunit abolishes synaptic responses through
GABAA receptors (Schweizer et al., 2003; Wulff et al., 2007,
2009a,b), since the 2 subunit anchors GABAA receptors at syn-
apses and allows a sufficient single-channel conductance of
25–30 pS (Seeburg et al., 1990; Lorez et al., 2000; Schweizer et al.,
2003). Removal of 2 subunits leaves low-
conductance -type GABAA receptors
that are extrasynaptic. A SHIRPA screen
showed that the HDC-2 mice were in-
distinguishable from their littermate
controls in health, behavior, and ap-
pearance (Table 1). In situ hybridization
with an exon 4-specific 2 subunit probe
showed no gross change in 2 expression
in any non-TMN brain region of HDC-
2 mice compared with littermate con-
trol mice (see Fig. 5A); the GABAA
receptor 2 gene is widely expressed in the
adult mouse brain (Cope et al., 2004;
Wulff et al., 2007, 2009a,b). Expression of
2 mRNA was unchanged in the thala-
mus, where its expression was weak in lit-
termate controls (see Fig. 5Aii, DLG),
hypothalamus (see Fig. 5Ai, VMH), and
other brain areas such as the cerebellum
and brainstem (see Fig. 5Aiii). In the
TMN region, the 2 signal was diffuse in
both littermate control and knock-out
groups (see Fig. 5Aii); as histaminergic
cells are scattered in this region (Fig. 4A),
it was difficult to see a change in 2mRNA
signal. However, immunocytochemistry
with a 2 subunit-specific antibody
showed loss of signal in HDC-positive
neurons (Fig. 5B), but not other brain re-
gions. To further confirm loss of synaptic
GABAA receptors, we recorded currents
in whole-cell voltage-clamped neurons in
acute adult slices containing the ventral
TMN (Zecharia et al., 2009). Fast GABAA
receptor-mediated IPSCs were absent
from ventral TMN neurons in the HDC-
2 mice, but were present in those from
littermate controls (Fig. 5C).
The results obtained with the HDC-Cre  Rosa26 crosses
implied that synaptic inhibition in HDC-2 mice might be
affected in some additional brain regions, such as a subset of
thalamic relay nuclei (Fig. 3). We investigated whether this
had happened for neurons in acutely prepared slices of the
DLG nucleus. GABAA receptor-mediated inhibition in these
thalamic relay neurons is a mixture of synaptic IPSCs and
extrasynaptic tonic currents, with the majority of charge car-
ried by the 4-type GABAA receptors (Belelli et al., 2005,
2009; Jia et al., 2005, 2009; Bright et al., 2007; Brickley and
Mody, 2012). We found that the occurrence of IPSCs in DLG
neurons had changed between HDC-2 and littermate con-
trol mice. Even in control neurons, GABAergic IPSCs were not
always observed (Fig. 5Di, see example). However, 12 of 16
(85%) neurons in littermates (Fig. 4Dii), but only 4 of 13
(30%) DLG neurons in HDC-2 mice had IPSCs (Fig. 5E).
This difference was significant ( 2 test,  2	 7.35; df	 1; p	
0.01). As approximately a third of theHDC-2 DLG neurons
still have IPSCs, this partial ablation has most likely come
about because Cre expression was transient during develop-
ment, and, in contrast to the Rosa locus, the 2lox allele may
not be as susceptible to recombination unless sustained Cre
levels are present (see Discussion).
Figure3. hdcgeneexpressionandexaminationof Cre recombinaseactivityusing theROSA26 reportermouse. Thehdcgenewas
only expressed in the TMN in adult wild-typemice. A,B, hdc in situ hybridizationwith a 33P-labeled probe specific for HDC (A) and
the corresponding Nissl-stained section (B). Arrowheads indicate the TMN region in both panels. C, Coronal brain section showing
-galactosidase staining (Cre recombination-positive, blue) in the TMN from ROSA26  HDC-Cre crosses. D, Double-
immunofluorescent labeling for -galactosidase (green) and HDC (red) protein in coronal TMN sections from ROSA26 lacZ
HDC-Cremice indicates efficient recombination in histaminergic neurons. E, F,-galactosidase staining was also seen in the DLG
VPL, and VMH. Scale bars: A–C, E, F, 2 mm; D, 25m.
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HDC neurons lacking synaptic GABAA receptors are
more excitable
We performed whole-cell current-clamp recordings in TMN
neurons to examine whether the removal of synaptic GABAA
receptors had affected the excitability of these cells (Fig. 6). TMN
neurons fromHDC-2 mice had a resting membrane potential
(RMP) of45.8
 2.0 mV (n	 9) compared with49.1
 1.6
mV (n	 8) in littermates: a small but significant depolarization
(*p 0.05, Mann–Whitney test). We also observed a significant
leftward shift of the action potential frequency–current input
( f–I) curve in the2 knockout comparedwith littermate controls
(Fig. 6B).More action potentials were produced for a given amount
of current injection, and the current required to reach threshold for
action potential generation was significantly (*p 0.05) reduced in
the knockout (5.0
 1.4 pA, n	 9) compared with littermate con-
trols (12.7
 2.3 pA, n	 6) (Fig. 6C). Furthermore, removal of the
2 subunit significantly (***p 0.01) increased themembrane time
constant (m) of knock-out neurons (23.4
 1.7 ms, n	 9) com-
paredwith those from littermates (11.5
 1.7ms, n	 8), consistent
with a loss of channels (Fig. 6D).
Figure4. Distribution of EGFP-immunoreactive neurons in theHDC-EGFPmouse.A, Coronal sections through the ventrolateral TMNof anHDC-EGFPmousebrain. Top, A low-magnification image
(scale bar, 250m). Bottom, High-magnification images (scale bar, 50m). Immunostaining against EGFP selectively labeled histaminergic cells in this region, as shown by double labeling with
an anti-HDC antibody. EGFP immunoreactivity was also in ependymal cells capping the mammillary recess (arrowhead). B–E, We classified histaminergic neurons into three subgroups along the
mediolateral axis, beginning with the most rostral and progressing caudally. Wemapped the location of each EGFP-positive neuron: their positions are illustrated as triangles. The illustration in B
shows these groups as theMTM, DTM, and VTM, respectively. In each panel, a low-magnification image is on the top right (scale bar, 500m) alongside a high-magnification image on the top left
(scale bar, 50m). mt, mammillothalamic tract; f, fornix; 3V, third ventricle.
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GABAA receptor removal from histaminergic neurons does
not affect the sleep–wake cycle
GABAergic inhibition onto histaminergic neurons is hypothe-
sized to produce sleep induction and maintenance (Saper et al.,
2010; Haas and Lin, 2012). We therefore examined the sleep–
wake cycle inHDC-2mice (Fig. 7). For this, we usedNeurolog-
ger 2 devices (Pang et al., 2009;Vyssotski et al., 2009), which allow
uninterrupted recordings on untethered mice for 24 h. Record-
ings were made in the home cage.HDC-2 and their littermate
controls did not differ in any variable examined: EEG power
spectrum (Fig. 7B), total sleep–wake time (Fig. 7C), and duration
of REM and NREM periods over the 24 h cycle.
GABAB receptor removal from histaminergic neurons does
not affect the sleep–wake cycle
Given the lack of effect of synaptic GABAA receptor deletions
from histaminergic neurons on the sleep–wake cycle, we next
considered whether metabotropic GABAB receptors could be
playing a role. In GABAB receptor total knock-out mice, and
those with GABAB receptors specifically removed from orexiner-
gic neurons, sleep is more fragmented (Matsuki et al., 2009; Vi-
enne et al., 2010). We thus specifically inactivated the GABAB
receptor R1 subunit gene in histaminergic cells (seeMaterials and
Methods). The GABAB R1 subunit is essential for the formation
of GABAB receptors (seeMaterials andMethods).We crossed the
HDC-Cre line with GABAB1-lox mice (Haller et al., 2004) to
produce HDC-B1 mice. By SHIPRA behavioral assessment,
mice from these crosses appeared healthy (Table 1). Similar to the
results obtainedwith theHDC-2mice,HDC-B1mice did not
differ in EEG or sleep–wake parameters compared with litter-
mate controls (Fig. 7D–F).
To confirm loss of the GABAB1 subunit, we first used in situ
hybridization with a GABAB R1-selective oligonucleotide probe.
This showed no difference in signal between HDC-B1 and lit-
termate control coronal sections for any brain region examined
(Fig. 8A). GABAB is found onmost, if not all, neuronal cell types
(Kulik et al., 2002), and any loss of mRNA hybridization signal
from dispersed neurons in the small TMN area would be hard to
ascertain (Fig. 5A). However, immunocytochemistry of the ven-
tral TMN area with a GABAB R1-selective antibody revealed se-
Figure 5. GABAA receptor 2 subunit expression in HDC-2 mice. A, X-ray film autoradiographs showing in situ hybridization of GABAA receptor 2 subunit mRNA in brain sections from
littermate control andHDC-2 adultmice (scalebar, 1mm).B, Brain sections from littermateandHDC-2miceweredouble stainedwithanti-2 (left) andanti-HDC (middle) antibodies.Merged
images of TMN neurons are shown on the right for each genotype (scale bar, 25m). C, Current traces from whole-cell voltage-clamp recordings from HDC-2 (top) and littermate (bottom)
histaminergic neurons. GABAergic synaptic activitywas strongly compromised in knock-outmice comparedwith littermate controls.D,E, Current traces recorded in the DLG from littermate (D) and
HDC-2 (E) adult mice, show this population of neurons comprises cells without (Di, Ei) and with (Dii, Eii) IPSCs in both genotypes.
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lective loss of GABAB R1 subunit in cells
that were stained with HDC antibody
(Fig. 8B).
HDC-2mice have a delayed
habituation to a new environment
Activating the histaminergic system pro-
duces wakefulness and an enhanced abil-
ity to attend to the environment
(Parmentier et al., 2002; Haas and Panula,
2003; Passani and Blandina, 2011; Haas
and Lin, 2012). We therefore examined
HDC-2 and HDC-B1 mice and their
littermate controls in a “litter change”
paradigm, using the Neurologger 2 to as-
say their behavioral state (Fig. 9). Chang-
ing the bedding of the home cage was
stimulating for mice: both littermate and
HDC-2 mice were strongly aroused (as
shown by the percentage of time spent in
the wake phase) on exposure to novelty
(i.e., placing them into a new home cage
containing clean litter). However, HDC-
2 mice took longer to reduce their level
of arousal, remaining awake for 254.2 

15.6 min (n 	 6) after the litter change,
compared with 184.4 
 25.2 min for lit-
termates (n	 8, p	 0.05). We calculated
the degree of arousal (asmeasured by time
spent in the wake phase; Fig. 9, inset) for
each animal for a period of 75 min, start-
ing from when the first sleep episode was
observed in the entire cohort. Littermate
controls were significantly more variable
in this measure (p  0.0001, F test), and
were awake on average 83.4
 6.9% (n	
8) of this 75 min period, compared with
99.8 
 0.1% for HDC-2 mice (n 	 6).
The GABAA receptor knockouts had a significantly elevated level
of arousal (p 0.05).Wedid the same litter change assaywith the
GABAB receptor-deleted HDC-B1 mice. Again, mice were
highly aroused after exposure to clean bedding, but the arousal
level in the 75 min following the first observed sleep period (any
animal) was identical (p  0.5) for HDC-B1 mice (61.2 

11.1%, n	 8) and littermate controls (60.0
 12.0%, n	 8). So,
this effect was selective for fast synaptic inhibition onto histamin-
ergic neurons.
Removal of propofol sensitivity from histaminergic neurons
does not affect propofol-induced loss of righting reflex
Histaminergic TMN neurons may be important targets of the
general anesthetic propofol (Nelson et al., 2002; Zecharia et
al., 2009). This drug enhances the potency of GABA at 2
subunit-containing GABAA receptors when applied at con-
centrations that produce LOC in vivo (Franks, 2008). We ex-
amined LORR, a correlate of LOC, after intravenous propofol
in littermate and HDC-2 mice (Fig. 10A). Following 10
mg/kg propofol (administered into the tail vein), littermates
regained their righting reflex after 1.0 
 0.3 min (n 	 4), a
similar sleep time to that observed in HDC-2 mice (1.3 

0.2 min, n 	 6). Duration of LORR was also identical follow-
ing a higher dose (30 mg/kg) of propofol: anesthesia time for
littermates was 6.3 
 0.3 min (n 	 4) and 5.7 
 0.4 min for
HDC-2 mice (n 	 5).
We also examined whether the ability of propofol to produce
motor sedation was affected by removal of the 2 subunit. We
administered either 20% Intralipid vehicle or 50 mg/kg, i.p.,
propofol to littermates (n	 5) andHDC-2 mice (n	 9), and
recorded activity levels as ameasure ofmotor sedation. Propofol-
induced motor sedation was unaltered: activity was reduced by
51.4 
 14.4% in littermates and by 56.3 
 15.1% in HDC-2
mice (p 0.5).
However, at the cellular level the ability of propofol to hyper-
polarize TMN neurons was abolished by removal of the 2 sub-
unit. We performed whole-cell current-clamp recordings in the
presence of propofol (1.5 M) and recorded the RMP compared
with control ACSF. Propofol significantly hyperpolarized TMN
neurons from littermate controls (**p 0.01, Fig. 10B) but had
no effect on histaminergic neurons recorded in brain slices from
the HDC-2 knock-out mice (Fig. 10C). This indicates that
although histaminergic neurons are no longer a cellular target for
propofol in the HDC-2 knock-out mice, these cells are not
behaviorally relevant for the actions of the drug.
Discussion
We studied how fast and slow GABAergic inhibition onto hista-
minergic neurons regulates behavior. Because the TMN is heter-
ogeneous, and the HDC-positive cells are dispersed (Fig. 4),
Figure 6. Histaminergic neurons aremore excitable in HDC-2mice. A, Voltage recording from a typical histaminergic
neuron with characteristic Ih sag (*) and transient outward current (**). The current injection protocol is shown below (800
ms pulse,40 to 60 pA in 2 pA increments). B, Typical f–I curves for littermate (black) and HDC-2 (gray) neurons,
illustrating a leftward shift in the knockout, but no change in slope. C, Averaged data showing a significant ( p 0.05)
reduction in the current required to reach AP threshold in the knockout (n	 9) compared with littermate controls (n	 8).
D, HDC-2 histaminergic neurons had a slightly depolarized (*p 0.05) membrane potential (45.8
 2.0 mV, n	 9)
compared with littermates (49.1
 1.6 mv, n	 8). The m was calculated from a series of brief step pulses (0.5 ms
pulse, 100 pA to threshold) and was significantly slower (***p 0.001) in knockouts (23.4
 1.7 ms) compared with
littermate controls (11.5
 1.7 ms).
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genetic methods have clear advantages. Therefore, we used the
Cre/LoxP system to remove ionotropic (fast) and metabotropic
(slow) GABAergic signaling from histaminergic neurons and ex-
amined the effects on the sleep–wake cycle, how the animals re-
acted to behavioral stimulation, and propofol-induced motor
sedation and loss of righting reflex. Surprisingly, we found that
the natural sleep–wake cycle and EEG were unaffected. GABAe-
rgic inhibition onto histaminergic cells as amechanism to induce
natural sleep is dispensable. In addition, and contrary to our
previous thinking (Nelson et al., 2002; Zecharia et al., 2009),
histaminergic neurons also do not seem to be principal cell types
for propofol-induced loss of consciousness. However, fast inhi-
bition onto histaminergic neurons is
needed for an ecologically important be-
havior, habituation to novelty.
Histamine has an undisputed ability to
promote wakefulness: HDC knock-out
mice, which cannot synthesize histamine,
fall asleep during novel situations and at the
start of “lights-off” (Parmentier et al., 2002;
Anaclet et al., 2009); andH1 receptor antag-
onists cause strong sedation (Haas and
Panula, 2003; Wafford and Ebert, 2008).
Histaminergic neurons have been proposed
as the major downstream node through
which orexin promotes arousal (Peyron et
al., 1998; Eriksson et al., 2001; Huang et al.,
2001;Torrealba et al., 2003; Johnet al., 2004;
Mochizuki et al., 2011).
The firing of histaminergic neurons is
behaviorally state dependent: they do not
fire action potentials during non-REM or
REM sleep, start firing action potentials
shortly after waking, and fire more during
active than quiet waking (Takahashi et al.,
2006; Sakai et al., 2010). Much interest cen-
ters on what turns histaminergic neurons
off at the onset of sleep, keeps them off dur-
ing sleep, and then turns them on, or allows
them to start firing again, shortly after wak-
ing. Various transmitters inhibit histamin-
ergic cells (Scho¨nrock et al., 1991; Yang
and Hatton, 1997; Oishi et al., 2008),
with GABA and galanin being the most
prominent (Scho¨nrock et al., 1991;
Yang and Hatton, 1997; Sergeeva et al.,
2002). The most popular hypothesis is
the flip-flop model of sleep–wake
switching, whereby GABAergic preoptic
hypothalamic nuclei suppress histamin-
ergic firing during sleep (Sherin et al.,
1996, 1998; Szymusiak et al., 1998; Saper
et al., 2010). The sleep–wake cycle and
EEG were unaffected, however, in either
HDC-2 or HDC-B1 mice. On the
other hand, the adaptability and plastic-
ity of the sleep–wake system following
chronic tissue or genetic lesions is well
known (Blanco-Centurion et al., 2007;
Winsky-Sommerer, 2009; Saper et al.,
2010). Multiple transmitters and nuclei
in the ascending arousal system regulate
the sleep–wake cycle. This could indi-
cate that maintaining an unchanged sleep–wake cycle is of
such deep importance that many systems can independently
preserve it. Yet at a cellular level, HDC-2 histaminergic
neurons have no IPSCs, and are more depolarized and excit-
able. Other studies have also demonstrated that genetic 2
removal ablates synaptic GABAA receptors completely, with
no “replacement” IPSCs appearing (Schweizer et al., 2003;
Wulff et al., 2007, 2009a,b). So, if there has been compensation
in HDC-2 mice, it must be at the systems level. Alterna-
tively, our results may simply mean that inhibition of hista-
minergic neurons, via GABA at least, plays no role in the
regulation of the sleep–wake cycle.
Figure7. Natural sleep parameterswere unchanged inHDC-2 andHDC-B1mice.A,D, Representative EEG and EMG traces
from littermates during periods of WAKE, NREM sleep, and REM sleep in HDC-2 and HDC-B1 mice, respectively. B, Power
spectral analysis of EEG traces demonstrates that cortical activity in HDC-2 mice (n	 9) was identical to littermates (n	 9)
across the three behavioral states. C, The time spent in each phase of the sleep–wake cycle was not affected by the 2 subunit
deletion. E, F, Cortical activity (E) and time spent in each behavioral state (F ) were also unchanged in HDC-B1 mice (n	 7)
compared with littermate controls (n	 8).
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Alert and attentivewaking is associated
with elevated histaminergic neuron firing
(Takahashi et al., 2006, 2010; Sakai et al.,
2010). The HDC-2 knockouts show
that “relaxation,” or wind down, of ex-
ploratory behavior requires GABAA, but
not GABAB, receptor-driven inhibition of
histaminergic neurons. Eventually, the
HDC-2 knock-out animals do settle,
but it takes longer. In other words, habit-
uation to novelty by inhibiting histamin-
ergic neurons is active, not passive, and
requires ongoing fast inhibition. This hy-
perarousal phenotype gives us confidence
in concluding that our “negative” results
on the sleep–wake cycle reflect the physi-
ological role played by the histaminergic
system. During the waking state, inhibi-
tory signals to histaminergic cells could
reduce responses to novelty or enable the
brain to downplay stimuli. If the environ-
ment is nonthreatening and there is little
to prompt exploratory behavior, mice
show low arousal (i.e., they spend time
when not sleeping in a “quiet waking”
state). Individuals that waste energy and
attract predators by hyperactivity would
be at a disadvantage.
Given the potential strategic impor-
tance of the inhibitory GABAergic input
onto histaminergic neurons in suppress-
ing arousal (see above), we previously
suggested that these neurons are key
nodes where propofol acts to induce loss
of consciousness (Nelson et al., 2002;
Zecharia et al., 2009). At the doses used in
clinical anesthesia, propofol works as a
powerful allosteric modulator of GABAA
receptors that contain 2 and/or 3 sub-
units (Jurd et al., 2003; Reynolds et al.,
2003; Rudolph andMohler, 2004; Franks,
2008). Thedrugdoes not gate the receptors
directly, but potently enhances GABA’s
ability to induce a chloride flux though
the receptor; consequently, IPSCs are
strongly prolonged. Histaminergic neu-
rons express 3 subunits (Zecharia et al.,
2009), and indeed propofol enhances any
active GABA inputs onto histaminergic
neurons (Zecharia et al., 2009). At the cel-
lular level, we found that selective deletion
of 2-type GABAA receptors abolished
the inhibitory effects of propofol on hista-
minergic neurons (Fig. 10). However, at
the whole animal level, this had no impact
on the ability of this drug to produce
motor sedation or loss of consciousness (Fig. 10). Thus, inhi-
bition of histaminergic neurons is probably coincident with,
rather than necessary for, the behavioral effects of propofol.
This contradicts our previous conclusion based on the effects
of local infusion of GABAergic drugs into the TMN region
(Nelson et al., 2002): these drugs may have, in fact, reached
additional targets.
TheHDC-Cremice described here should be useful for study-
ing many aspects of the histaminergic system, but it is necessary
to comment on the unexpected Cre expression. For the adult
rodent brain, in situ hybridization (Fig. 3A) (Bayliss et al., 1990;
Karlstedt et al., 2001) and gene knock-in HDC-EGFP (Fig. 4)
mapping all show that HDC gene expression is confined to the
TMN and the ependyma. Karlstedt et al. (2001) did not report
Figure 8. GABAB1 receptor subunit expression inHDC-B1mice.A, X-ray film autoradiographs showing in situ hybridization of
GABAB1 receptormRNA in brain sections from littermate control andHDC-B1 adultmice (scale bar, 1mm).B, Brain sections from
littermate and HDC-2 mice were double stained with anti-B1 (left) and anti-HDC (middle) antibodies. Merged images of TMN
neurons (arrowheads) are shown on the right for each genotype (scale bar, 25m).
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developmental expression of the hdc gene in the thalamus during
embryonic or postnatal development. The lacZ expression in the
ROSA26HDC-Cre crosses was, however, in areas additional to
the TMN and ependyma, indicating a probable transient expres-
sion of the hdc gene at an earlier time in these circuits. Indeed,
when we inspected the on-line, but unannotated, Brain Gene
Expression Map (BGEM) in situ hybridization atlas, we found
that there was weak expression of the hdc gene in a subset of
(undescribed) thalamic nuclei at P7, but not in adults
(Magdaleno et al., 2006) (see: http://www.stjudebgem.org/web/
view/probe/viewProbeDetails.php?id 	 2069). Therefore, hista-
mine might be synthesized transiently by selected thalamic
nuclei during postnatal development. Consistent with the
Rosa crosses, approximately two-thirds of the neurons in the
DLG thalamic nucleus had disrupted synaptic GABAA recep-
tors (Fig. 5Ei). Nevertheless, it is worth emphasizing that a
third of the HDC-2 neurons still had normal IPSCs (Fig.
5Eii). We think this incomplete penetrance is because floxed
gene loci vary in the accessibilities of their loxP sites to Cre
recombinase, with some floxed loci requiring strong and sus-
tained Cre expression before recombination occurs (e.g., the
floxed Bmal 1 gene) (Husse et al., 2011). It depends on the
particular local chromatin structure. The transient develop-
mental IRES-driven expression of Cre in the non-TMN areas
might not be sufficient for full recombination at all floxed loci.
Based on the DLG electrophysiology results, a small num-
ber of other brain nuclei in the HDC-2 mice, in addition to
the histaminergic neurons, are likely to have some depleted
IPSCs. Would these additional deficits contribute to the de-
layed habituation to novelty of the HDC-2 mice? Classi-
cally, the DLG thalamic nucleus processes visual input; the
ventral posterior medial thalamic nucleus handles somatosen-
sory information (Willis, 1997); the VMH nucleus regulates
satiety and energy homeostasis (Barsh and Schwartz, 2002).
Since the GABAB R1 receptor knockouts generated with the
same HDC-Cre line were unchanged on any behavioral pa-
rameter, thus serving as further internal controls, we can say
that the habituation to novelty deficit is not due to defective
GABA inhibition per se.
In summary, the flip-flop model of sleep–wake switching,
with its reciprocal inhibitory connections between preoptic
hypothalamic nuclei and the TMN, is central to current think-
ing (Saper et al., 2010). There is certainly a substantial GABAe-
rgic innervation of histaminergic neurons (Yang and Hatton,
1997; Sherin et al., 1998; Steininger et al., 2001). However, our
data suggest that a primary function of this GABAA receptor-
mediated inhibition is to dampen vigilant arousal. It does not
appear to influence the loss of consciousness associated with
either natural sleep or propofol-induced anesthesia. We be-
lieve that other neuronal populations are likely to control this
switch, although other factors acting on histaminergic neu-
rons, such as galanin coreleased with GABA from preoptic
nuclei (Scho¨nrock et al., 1991), cannot be excluded. Whether
propofol targets other circuitry responsible for sleep remains
an open question.
Figure 9. Fast GABAergic synaptic transmission onto histaminergic neurons is essen-
tial for habituation to a novel environment. A, Both littermate (n	 8) and HDC-2 (n	
6) mice displayed profound arousal on exposure to novelty (i.e., placing them into a new
home cage containing clean litter at time 0). However, HDC-2 mice took longer to
reduce their level of arousal. The main graph shows the percentage of time spent in the
wake phase, and the inset shows the percentage of time spent awake for 75 min following
the first observed sleep episode in each cohort (*p 0.05). B, HDC-B1mice (n	 8) and
littermate controls (n	 8) also displayed hyperarousal on being exposed to new litter,
but there was no difference between the duration of arousal between genotypes in this
case (inset).
Figure 10. Histaminergic neurons are not a physiological target for propofol anesthe-
sia. A, Propofol-induced LORR is identical in HDC-2 mice compared with littermate
controls when administered intravenously at 10 mg/kg (n	 6 and n	 4, respectively)
and 30 mg/kg (n 	 5, n 	 4, respectively). B, The RMP of TMN neurons was more
hyperpolarized in the presence of propofol (58.9 
 2.2 mV, n 	 8) compared with
control conditions (49.1 
 1.6 mV, n 	 8). C, However, in HDC-2 histaminergic
neurons, the control RMP (45.8 
 2.0 mV, n 	 9) was unchanged by propofol
(47.2
 2.1 mV, n	 10).
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